Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Merus N.V. CS (MRUS)

19.27 +0.15 (+0.78%)

5/25/2017  4:00pm

Open:

19.19

Pre. Close:

19.12

High:

19.63

Low:

19.01

Volume:

22,015

Market Cap:

309.96M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-05-25 4:46:39 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 25.39     One year: 27.74

Support:

Support1: 18.49    Support2: 15.38

Resistance:

Resistance1: 21.74    Resistance2: 23.75

Pivot:

20.25

Moving Averages:

MA(5): 19.41     MA(20): 20.39

MA(100): 23.63     MA(250): 16.94

MACD:

MACD(12,26): -0.62     Signal(12,26,9): -0.56

%K %D:

%K(14,3): 12.59     %D(3): 8.56

RSI:

RSI(14): 38.08

52-Week:

High: 33.63  Low: 7.26  Change(%): 152.9

Average Vol(K):

3-Month: 36  10-Days 21

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MRUS has closed above bottom band by 17.0%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to MRUS's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 23 Dec 2016 15:21:54 GMT
Merus NV Executives Discuss Products And Plans Going Into 2017: 'We Have ...

Wed, 17 May 2017 21:00:00 GMT
Merus NV (MRUS) Reports Positive Results from MCLA-128 Phase 1/2 Study in ...

Mon, 26 Oct 2015 23:09:53 GMT
19.42

Wed, 09 Nov 2016 12:00:00 GMT
Merus NV Receives €1.5 Million EUREKA Eurostars Grant with Aquila BioMedical ...

Tue, 24 May 2016 18:11:15 GMT
Merus NV Announces Closing of Initial Public Offering

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

16.00

Shares Float (M)

3.18

% Held by Insiders

% Held by Institutions

Shares Short (K)

25

Shares Short Prior Month (K)

24

Stock Financials

EPS

-3.890

EPS Est. Current Year

-0.780

EPS Est. Next Year

-2.700

EPS Est. Next Quarter

-0.570

Forward EPS

Book Value (p.s.)

2.310

PEG Ratio

Profit Margin

Operating Margin

-580.14

Return on Assets (ttm)

-23.0

Return on Equity (ttm)

-44.8

Qtrly Rev. Growth

246.6

Gross Profit (p.s.)

-0.726

Sales Per Share

0.186

EBITDA (p.s.)

-1.769

Qtrly Earnings Growth

Operating Cash Flow (M)

-25.90

Levered Free Cash Flow (M)

-15.09

FoxReading.com

Valuation

P/E

-4.95

P/E Growth Ratio

0.01

P/BV

8.34

P/S

103.81

P/CF

-11.90

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.